1. Short title This Act may be cited as the Synthetic Drug Control Act of 2017 . 2. Treatment of certain designer drugs as schedule I controlled substances (a) In general Not later than 180 days after the date of enactment of this Act, the Attorney General of the United States shall update schedule I under section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) to include, unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of a substance listed in paragraphs (1) through (9), or which contains the salts, isomers, and salts of isomers thereof whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation. The substances referred to in the preceding sentence are the following: (1) Phenylalkylamines The substances listed in this paragraph consist of the following phenylalkylamines: (A) 1-(4-Ethylphenyl)-2-(methylamino)-1-propanone. (B) 1-(4-Methoxyphenyl)-2-(methylamino)-1-propanone. (C) 2-(Ethylamino)-1-(4-methoxyphenyl)-1-propanone. (D) 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)-1-propanone. (E) 2-(Ethylamino)-1-phenyl-1-propanone. (F) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanone. (G) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-propanone. (H) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-propanone. (I) 2-Amino-1-(4-fluorophenyl)propan-1-one. (J) 2-(Ethylamino)-1-(4-ethylphenyl)-1-propanone. (K) 2-(Dimethylamino)-1-phenyl-1-propanone. (L) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-butanone. (M) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone. (N) 2-(Methylamino)-1-phenyl-1-butanone. (O) 2-(Methylamino)-1-(4-methylphenyl)-1-butanone. (P) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-butanone. (Q) 1-(3,4-Dimethylphenyl)-2-(methylamino)-1-propanone. (R) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-propanone. (S) 2-(Benzylamino)-1-(4-methylphenyl)-1-propanone. (T) 1-(1-Naphthyl)-2-(1-pyrrolidinyl)-1-pentanone. (U) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-propanone. (V)